DexCom, Inc. (BVMF:D1EX34)

DexCom Statistics

Total Valuation

DexCom has a market cap or net worth of BRL 123.12 billion. The enterprise value is 119.17 billion.

Market Cap	123.12B
Enterprise Value	119.17B

Important Dates

The next estimated earnings date is Friday, February 13, 2026.

Earnings Date	Feb 13, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-1.89%
Shares Change (QoQ)	-0.20%
Owned by Insiders (%)	0.32%
Owned by Institutions (%)	93.54%
Float	387.37M

Valuation Ratios

The trailing PE ratio is 32.06 and the forward PE ratio is 24.52.

PE Ratio	32.06
Forward PE	24.52
PS Ratio	5.12
PB Ratio	8.47
P/TBV Ratio	8.81
P/FCF Ratio	21.76
P/OCF Ratio	15.95
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 21.26, with an EV/FCF ratio of 21.06.

EV / Earnings	31.03
EV / Sales	4.98
EV / EBITDA	21.26
EV / EBIT	28.93
EV / FCF	21.06

Financial Position

The company has a current ratio of 1.56, with a Debt / Equity ratio of 0.94.

Current Ratio	1.56
Quick Ratio	1.35
Debt / Equity	0.94
Debt / EBITDA	2.43
Debt / FCF	2.43
Interest Coverage	40.93

Financial Efficiency

Return on equity (ROE) is 30.63% and return on invested capital (ROIC) is 9.85%.

Return on Equity (ROE)	30.63%
Return on Assets (ROA)	7.02%
Return on Invested Capital (ROIC)	9.85%
Return on Capital Employed (ROCE)	18.68%
Revenue Per Employee	2.35M
Profits Per Employee	374,722
Employee Count	10,300
Asset Turnover	0.65
Inventory Turnover	3.06

Taxes

In the past 12 months, DexCom has paid 1.27 billion in taxes.

Income Tax	1.27B
Effective Tax Rate	24.85%

Stock Price Statistics

The stock price has decreased by -25.45% in the last 52 weeks. The beta is 1.52, so DexCom's price volatility has been higher than the market average.

Beta (5Y)	1.52
52-Week Price Change	-25.45%
50-Day Moving Average	7.30
200-Day Moving Average	8.63
Relative Strength Index (RSI)	39.55
Average Volume (20 Days)	3,841

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.84

Income Statement

In the last 12 months, DexCom had revenue of BRL 24.07 billion and earned 3.84 billion in profits. Earnings per share was 9.58.

Revenue	24.07B
Gross Profit	14.20B
Operating Income	4.14B
Pretax Income	5.11B
Net Income	3.84B
EBITDA	5.45B
EBIT	4.14B
Earnings Per Share (EPS)	9.58

Balance Sheet

The company has 17.70 billion in cash and 13.73 billion in debt, giving a net cash position of 3.98 billion.

Cash & Cash Equivalents	17.70B
Total Debt	13.73B
Net Cash	3.98B
Net Cash Per Share	n/a
Equity (Book Value)	14.53B
Book Value Per Share	37.25
Working Capital	10.04B

Cash Flow

In the last 12 months, operating cash flow was 7.72 billion and capital expenditures -2.06 billion, giving a free cash flow of 5.66 billion.

Operating Cash Flow	7.72B
Capital Expenditures	-2.06B
Free Cash Flow	5.66B
FCF Per Share	n/a

Margins

Gross margin is 59.01%, with operating and profit margins of 17.22% and 15.96%.

Gross Margin	59.01%
Operating Margin	17.22%
Pretax Margin	21.24%
Profit Margin	15.96%
EBITDA Margin	22.63%
EBIT Margin	17.22%
FCF Margin	23.51%

Dividends & Yields

DexCom does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.89%
Shareholder Yield	1.89%
Earnings Yield	3.12%
FCF Yield	4.60%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on June 13, 2022. It was a forward split with a ratio of 4.

Last Split Date	Jun 13, 2022
Split Type	Forward
Split Ratio	4

Scores

DexCom has an Altman Z-Score of 5.5 and a Piotroski F-Score of 6.

Altman Z-Score	5.5
Piotroski F-Score	6